Limited Submission Funding Opportunity: St. Baldrick’s Foundation Scholar Awards

URLhttps://www.stbaldricks.org/file/Research/2022-SBF-Scholar-Guidelines.pdf

OBJECTIVES:

The St. Baldrick’s Foundation is a volunteer and donor powered charity committed to supporting the most promising research to find cures for childhood cancers and give survivors long and healthy lives.

The St. Baldrick’s Foundation works hard to be sure that every dollar makes the biggest impact possible in childhood cancer research. The Foundation has held several Research Priorities Summits with many of the country’s leading pediatric oncology researchers participating to advise the staff and board of directors on funding priorities. The St. Baldrick’s team and Scientific Advisors meet regularly to be sure St. Baldrick’s funds make the greatest impact on pediatric cancer research.

Current funding priorities are divided into four categories:

  • New discovery research
  • Translational research and early phase clinical trials
  • Phase III clinical trials & infrastructure support of participating institutions (primarily the fall grant cycle)
  • Education of new pediatric oncology researchers

In addition to research to understand the biology of childhood cancers and discover leads to more effective treatments, topics of interest include, but are not limited to:

  • Adolescents & young adults
  • Survivorship, outcomes, and quality of life
  • Supportive care
  • Epidemiology and pediatric cancer predispositions
  • Precision medicine
  • Alternative & complementary therapies

An institution may submit one application for this opportunity.

Limited Submissions Policy Exception: Each program/institution may submit one additional LOI/application in the Spring funding cycle in one program/funding category of their choice. This is one additional LOI/application overall for the cycle, not one additional LOI/application per program/category.

Due to high interest from donors and low numbers of past applications, the following qualify for the above limited submissions policy exceptions:

  • Brain tumors – all types, including rare forms
  • Burkitt lymphoma
  • Complementary and alternative therapies
  • Hepatoblastoma
  • Langerhans Cell Histiocytosis
  • Rhabdoid tumors

FUNDING INFORMATION:

Up to $110,000/year, two-year minimum to be used entirely for the Scholar’s salary and fringe at the applicant institution (no indirects).

 ELIGIBILITY RESTRICTIONS:

  • Applicants should hold a Ph.D., M.D., or D.O. degree in a field of research specialty by the date the award becomes effective and must currently hold (for no longer than seven years at the time the award begins), or will hold by start of the award, a title that is considered by the institution to be a full-time faculty position.
  • This is an early-career award. The Scholar award is intended to develop the independent pediatric cancer research careers of highly qualified investigators, not to support well established or senior investigators.
  • Scholars may receive funding from other sources to support their research. However, no other comparable or higher (monetary value) career development award may be held prior to or at the time the award begins. Scientific or budgetary overlap with other funded projects is not allowed.
  • Applicants holding or awarded R01s at the time of the LOI are not eligible to apply. Applicants cannot hold a NIH K-award at the time that they apply (institutional K12 funding is allowable).

INTERNAL SELECTION PROCESS:

Interested investigators should submit the following materials via InfoReady Review by DATE: 11/12/2021

  • Questions outlined in InfoReady Review application;
  • A brief statement (up to two pages) by the candidate describing their scientific achievements and proposed project;
  • A brief budget outline for the proposed research
  • Up-to-date CV or biosketch.

A faculty committee drawn from both campuses will review internal proposals and select nominees. Foundation Relations will work with the nominees to develop and submit the institutional nomination letter and applicant materials by 12/3/2021.

DEADLINES:

Internal Materials Due: Friday, November 12, 2021
Sponsor Deadline: LOI: Friday, December 3, 2021

Information For...